BRIVIACT FDA approval date

The FDA approved BRIVIACT on 18 Feb 2016.

FDA approval date
18 Feb 2016

Drug identity has not yet been verified against registry records

Also recorded as BRIVARACETAM

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2016-02-18DayBRIVIACTFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA205836", "applicant_as_listed_by_fda": "UCB INC", "brand_names": ["BRIVIACT"], "active_ingredients": ["BRIVARACETAM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20160218", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026